Accessing GLP-1 treatment in San Carlos, California has traditionally meant longer waits than mainland patients face. Mounjaro® is the FDA-approved Injectable pen Tirzepatide product by Eli Lilly. Weight Method's telehealth model is a separate program built for distance: licensed providers evaluate eligibility, and compounded Tirzepatide (dispensed by a U.S.-licensed 503A pharmacy) ships to any San Carlos address at $329/month. Compounded Tirzepatide is not FDA-approved.
FDA-approved Mounjaro prescribed by licensed providers. Delivered to your door.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · San Carlos is already seeing results
Mounjaro in San Carlos, CA: an FDA-approved GLP-1 medication shown to achieve 15-22% body weight loss in clinical trials. Weight Method offers Mounjaro to patients in San Carlos from $329/month with virtual consultations and direct-to-door shipping.
For many people in San Carlos, diet and exercise alone have not produced lasting results — and that is not a failure of willpower. Tirzepatide addresses hormonal drivers involved in body weight regulation. Mounjaro® is the FDA-approved Injectable pen Tirzepatide product by Eli Lilly, approved in 2022 for Type 2 diabetes. Weight Method offers a separate telehealth program: licensed providers evaluate eligible patients and prescribe compounded Tirzepatide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Tirzepatide is not FDA-approved. The program is priced at $329/month, including the evaluation, the medication, ongoing care, and home delivery to San Carlos.
San Carlos's suburban communities are hearing more about GLP-1 treatments through word of mouth and national media. Mounjaro® is the FDA-approved Injectable pen Tirzepatide product manufactured by Eli Lilly since 2022. Weight Method's separate program is straightforward: an online assessment, a virtual provider consultation, and compounded Tirzepatide delivered to your San Carlos address at $329/month. Compounded Tirzepatide is dispensed by a U.S.-licensed 503A pharmacy and is not FDA-approved.
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
Consult with a licensed provider in California and start Mounjaro from $329/month.
Get Started NowFree consultation. No commitment.